Cargando…
Tumor cell senescence response produces aggressive variants
Tumors often respond favorably to initial chemotherapy but eventually relapse with drug resistance and increased metastatic potential. Cellular senescence is a major therapeutic outcome of cancer chemotherapy, which leads to tumor stasis or regression through immune clearance of senescent cells. How...
Autores principales: | Yang, Leixiang, Fang, Jia, Chen, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563524/ https://www.ncbi.nlm.nih.gov/pubmed/28845296 http://dx.doi.org/10.1038/cddiscovery.2017.49 |
Ejemplares similares
-
SirT1 and rRNA in the nucleolus: regulating the regulator
por: Yang, Leixiang, et al.
Publicado: (2014) -
RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness
por: Benítez, Sandra, et al.
Publicado: (2021) -
Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma
por: Fazlollahi, Ladan, et al.
Publicado: (2019) -
Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population
por: Kim, Na-Yon, et al.
Publicado: (2021) -
Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
por: Pardella, Elisa, et al.
Publicado: (2022)